Amrutanjan Health Care Ltd

Amrutanjan Health Care Ltd

₹ 638 -0.81%
19 Apr - close price
About

AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink. [1]

Key Points

High Market Share in Modern Trade
Amrutanjan has maintained the No. 1 rank in Modern Trade in Head Category with the volume market share of 41.1%* in CY19. [1]

  • Market Cap 1,845 Cr.
  • Current Price 638
  • High / Low 775 / 556
  • Stock P/E 41.9
  • Book Value 90.6
  • Dividend Yield 0.72 %
  • ROCE 19.3 %
  • ROE 14.3 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 24.6%

Cons

  • Stock is trading at 7.04 times its book value
  • The company has delivered a poor sales growth of 11.5% over past five years.
  • Earnings include an other income of Rs.16.2 Cr.
  • Working capital days have increased from 79.3 days to 117 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
100 94 78 110 111 107 71 111 98 100 78 99 117
74 82 64 87 85 90 68 95 85 87 71 92 95
Operating Profit 26 12 15 23 26 16 3 16 12 13 7 7 22
OPM % 26% 13% 19% 21% 23% 15% 5% 14% 12% 13% 9% 7% 18%
3 3 3 4 3 5 3 3 4 5 4 4 4
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 2 1 1 1 2 2
Profit before tax 28 14 16 26 28 20 5 17 15 16 9 9 24
Tax % 25% 25% 26% 25% 26% 27% 30% 27% 26% 23% 26% 26% 26%
21 10 12 20 21 15 4 13 11 13 7 7 17
EPS in Rs 7.18 3.50 4.13 6.79 7.04 5.03 1.25 4.37 3.66 4.34 2.40 2.37 6.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
128 128 131 154 174 207 220 253 261 333 406 380 394
108 109 108 130 143 178 192 222 231 258 326 335 346
Operating Profit 20 19 23 25 32 29 28 31 31 75 80 45 49
OPM % 16% 15% 18% 16% 18% 14% 13% 12% 12% 22% 20% 12% 12%
5 4 3 5 6 7 8 7 8 11 15 15 16
Interest 3 2 2 1 0 0 0 0 0 1 1 0 0
Depreciation 3 3 3 2 3 2 3 3 4 4 4 5 6
Profit before tax 19 18 21 26 35 34 33 35 34 82 91 54 59
Tax % 29% 32% 32% 35% 35% 35% 39% 29% 27% 25% 26% 26%
13 12 15 17 22 22 20 25 25 61 67 40 44
EPS in Rs 4.57 4.15 4.97 5.86 7.68 7.47 6.84 8.39 8.58 20.93 22.99 13.63 15.15
Dividend Payout % 33% 36% 32% 30% 25% 26% 22% 26% 24% 20% 20% 34%
Compounded Sales Growth
10 Years: 11%
5 Years: 12%
3 Years: 13%
TTM: 2%
Compounded Profit Growth
10 Years: 13%
5 Years: 16%
3 Years: 17%
TTM: 5%
Stock Price CAGR
10 Years: 25%
5 Years: 16%
3 Years: 0%
1 Year: 4%
Return on Equity
10 Years: 20%
5 Years: 22%
3 Years: 24%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 3 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 78 85 94 102 118 113 126 143 156 213 262 288 259
22 13 6 0 0 2 0 0 2 1 1 1 1
22 26 22 25 28 34 38 42 44 57 84 70 92
Total Liabilities 124 127 124 130 149 152 166 188 205 274 350 362 355
19 17 15 13 22 27 28 26 26 23 28 49 50
CWIP 1 1 1 4 1 1 0 0 0 2 17 1 0
Investments 34 30 14 14 10 10 8 18 18 18 13 5 5
70 79 95 100 116 115 131 144 161 232 291 307 300
Total Assets 124 127 124 130 149 152 166 188 205 274 350 362 355

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
13 8 18 19 21 8 19 21 18 91 52 20
4 16 16 -5 1 -0 -8 -11 -14 -88 -36 -2
-27 -17 -14 -12 -11 -5 -9 -7 -12 -7 -17 -15
Net Cash Flow -9 8 20 2 12 3 2 3 -7 -4 -1 3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 37 78 66 62 55 51 46 47 37 19 34 32
Inventory Days 59 44 45 44 44 44 40 45 74 45 53 58
Days Payable 68 55 44 46 51 110 102 92 98 106 122 95
Cash Conversion Cycle 27 67 67 61 48 -15 -16 0 13 -41 -35 -6
Working Capital Days 33 57 54 42 45 80 26 30 71 29 92 117
ROCE % 19% 20% 24% 26% 29% 28% 25% 25% 23% 44% 38% 19%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
50.02% 50.02% 50.02% 50.02% 50.02% 50.02% 50.02% 50.03% 50.03% 50.59% 50.59% 50.59%
1.50% 1.53% 1.83% 1.43% 1.42% 0.87% 0.76% 0.68% 0.69% 0.75% 0.80% 1.38%
7.50% 6.94% 6.14% 6.14% 6.16% 6.30% 6.39% 7.18% 7.22% 7.10% 7.24% 7.29%
40.92% 41.41% 41.90% 42.23% 42.21% 42.62% 42.65% 41.93% 41.87% 41.39% 41.19% 40.66%
0.06% 0.10% 0.11% 0.18% 0.18% 0.18% 0.18% 0.18% 0.18% 0.18% 0.18% 0.07%
No. of Shareholders 33,71741,64061,36767,32366,17371,06472,10469,94771,42872,00268,40462,664

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls